Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

166
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
166
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

199
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
199
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

119
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
119
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

293
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
293
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

159
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
159
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

578
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
578
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 心血管医学と血液学
  9. 心臓病 (心血管疾患を含む)
  11. 急性covid-19心血管症候群の説明と提案された管理

急性COVID-19心血管症候群の説明と提案された管理

Nicholas S Hendren1, Mark H Drazner1, Biykem Bozkurt2

  • 1Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (N.S.H., M.H.D.).

Circulation
|April 17, 2020

関連する実験動画

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.6K

PubMed で要約を見る

まとめ
この要約は機械生成です。

COVID-19は急性心損傷を引き起こし,心筋不全や不律症として現れます. この心血管症候群の患者にとって 早期の認識と多分野的な治療は不可欠です

科学分野:

  • 心臓病科
  • 感染症
  • クリティカル ケア 医療

背景:

  • コロナウイルス病 2019 (COVID-19) パンデミックは,著しい罹病率と死亡率を引き起こす.
  • 入院した患者の一部は急性COVID-19心血管症候群を発症し,心臓損傷,心筋病変,心律失調,血液動力学的不安定が特徴です.
  • この心臓損傷の正確な原因は不明ですが,潜在的メカニズムには,心筋炎,マイクロ血管損傷,サイトカイン媒介の損傷,またはストレス関連の心筋病気が含まれます.

研究 の 目的:

  • 急性COVID-19心血管症候群の流行病学,病原性,診断,治療に関する現在のデータをレビューする.
  • この症候群の監視,診断,管理戦略を提案する.
  • 患者のリスクと医療従事者の被曝のバランスをとって 臨床結果を改善する

主な方法:

  • COVID-19 心血管症候群に関する利用可能な文献のレビュー.
  • ウイルスの複製と全身の炎症を含む潜在的な病原性メカニズムの分析.
  • 既存の証拠と臨床経験に基づく管理戦略の策定

主要な成果:

  • 急性COVID-19心血管症候群は,様々な臨床的症状を呈し,多くの場合,閉塞性冠動脈疾患なしに心臓損傷を含む.
  • 潜在的原因には,心臓に直接的なウイルスの影響,全身の炎症,およびストレス誘発の心筋症が含まれます.
キーワード:
コロナウイルスSARS-CoV-2について心筋病心不全

関連する実験動画

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.6K
  • 抗ウイルス薬や免疫調節剤を含む以前のコロナウイルスに対する経験から,治療戦略を評価しています.

    • 結論:

    • 急性COVID-19心血管症候群には,心臓病専門医,感染症専門医,重症病棟の医師を含む多学科アプローチが必要です.
    • 効果的な管理には 早期の認識と リスクを最小限に抑えながら 患者の結果を最適化する戦略が必要です
    • この複雑な状態の病原性を完全に解明し,治療プロトコルを精錬するには,さらなる研究とデータが必要です.
    心筋炎